Anthropic Opens Wet Lab for AI-Driven Drug Research

Anthropic, the artificial intelligence company, has established a physical wet lab in the San Francisco Bay Area to conduct real-world biological experiments, marking a significant expansion from its core AI development into the tangible world of drug research. The lab, confirmed by the company's head of life sciences, Eric Kauderer-Abrams, will use its Claude AI model to direct robotic units in running experiments with limited human intervention, focusing initially on preclinical research into rare and neglected diseases. The move represents a step beyond computer simulations, aiming to create a feedback loop where AI-generated hypotheses and molecule designs are validated by physical lab work, with results used to improve the models. "We believe that to do biology, the final test is still and will be for a while in real lab work," Kauderer-Abrams said. "We absolutely are doing that today." Anthropic's stated goal is to tackle diseases overlooked by traditional pharmaceutical companies due to economic considerations.